Your browser doesn't support javascript.
loading
JAK2 Inhibitor SAR302503 Abrogates PD-L1 Expression and Targets Therapy-Resistant Non-small Cell Lung Cancers.
Pitroda, Sean P; Stack, Melinda E; Liu, Gene-Fu; Song, Sui-Sui; Chen, Lucy; Liang, Hua; Parekh, Akash D; Huang, Xiaona; Roach, Paul; Posner, Mitchell C; Weichselbaum, Ralph R; Khodarev, Nikolai N.
Afiliação
  • Pitroda SP; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Stack ME; Department of Surgery, The University of Chicago, Chicago, Illinois.
  • Liu GF; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Song SS; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Chen L; University of Illinois College of Medicine at Chicago, Chicago, Illinois.
  • Liang H; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Parekh AD; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Huang X; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Roach P; Department of Surgery, The University of Chicago, Chicago, Illinois.
  • Posner MC; Department of Surgery, The University of Chicago, Chicago, Illinois.
  • Weichselbaum RR; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois.
  • Khodarev NN; Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois. n-khodarev@uchicago.edu.
Mol Cancer Ther ; 17(4): 732-739, 2018 04.
Article em En | MEDLINE | ID: mdl-29467274

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Sulfonamidas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Janus Quinase 2 / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirrolidinas / Sulfonamidas / Carcinoma Pulmonar de Células não Pequenas / Resistencia a Medicamentos Antineoplásicos / Inibidores de Proteínas Quinases / Janus Quinase 2 / Antígeno B7-H1 / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article